Phospho-ErbB2/ErbB4 (Y1248/1284) Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F3624-20UL

Regular price €199,00 EUR
Regular price Sale price €199,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Phospho-ErbB2/ErbB4 (Y1248/1284) is a target of interest in many antibody-based workflows. Phospho-ErbB2/HER2 (Tyr1248) and Phospho-ErbB4/HER4 (Tyr1284) are activated forms of two members of the ErbB receptor tyrosine kinase (RTK) family, which also includes EGFR/HER1 and ErbB3/HER3. These single-pass transmembrane glycoproteins have an extracellular ligand-binding domain, a single membrane-spanning region, and an intracellular tyrosine kinase domain. HER2 lacks a direct ligand and functions primarily as a preferred heterodimerization partner, whereas HER4 binds ligands such as neuregulins. Depending on the literature source, Phospho-ErbB2/ErbB4 (Y1248/1284) may also be discussed as Phospho-ErbB2/ErbB4 (Y1248/1284) and CD340.

Reported cellular context includes cell membrane, cell projection, cytoplasm, and endosome, which can matter when signal is compared across treatments or changing cell states. Following Phospho-ErbB2/ErbB4 (Y1248/1284) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

Phospho-ErbB2/ErbB4 (Y1248/1284) is commonly interpreted in the context of cancer, infectious disease, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cell projection, and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cell membrane, cell projection, and cytoplasm across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • host-response changes during infection or pathogen-associated stimulation
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Phospho-ErbB2/ErbB4 (Y1248/1284). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Phospho-ErbB2/ErbB4 (Y1248/1284) reflect biology rather than handling. When interpreting Phospho-ErbB2/ErbB4 (Y1248/1284), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Phospho-ErbB2/ErbB4 (Y1248/1284) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
ERBB2 • ERBB4
Research Area:
Cancer • Cell Signaling • Infectious Disease
Application:
FCM • IF • IP • WB
Reactivity:
Human
Specificity:
Phospho-ErbB2/ErbB4 (Y1248/1284) Antibody [K1P9] detects endogenous levels of total ErbB2/HER2 and ErbB4/HER4 protein only when phosphorylated at Tyr1248 and Tyr1284 respectively.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
K1P9
UniProt:
P04626Q15303
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.